Vial Announces $67M Series B Led by General Catalyst
Read Vial's feature in the WSJ

The Vial Preferred Site Network

Vial has built deep relationships with highly experienced, sought-after sites because we know quality investigators are at the core of successful clinical trials. The Vial Preferred Site Network connects dedicated sites to leading sponsors for more streamlined trials that bring new therapies to market faster.

Investigator Selection

Vial works diligently to build strong, long-lasting relationships with investigative sites across the globe. We ensure that each site has extensive experience in its respective therapeutic area and across various indications.

Each site in the Vial Preferred Site Network has undergone a comprehensive selection process. Vial ensures every site is equipped for streamlined trial execution via technology-enabled processes from site startup to database lock.

Expertise Across Therapeutic Areas

The Vial Preferred Site Network offers a robust investigator community across a wide range of therapeutic areas to deliver superior trial outcomes.

Oncology CRO

Dermatology CRO

Ophthalmology CRO

Gastroenterology CRO

Neurology CRO

Cardiology CRO

50+ Sites Nationwide

Why Join the Vial Preferred Site Network?

Grow your research business

Gain exclusive trial access

Offer novel therapies to patients

Run tech-enabled, streamlined trials

Join a network of the best investigators

Fully focus on the trial while Vial handles recruitment

Want access
to our preferred site network
for your next trial?
Connect with us today!

Accepting new sites across therapeutic areas. Join our preferred site network for access to leading sponsors and exclusive trials.

Contact Us

Note: If you are looking to participate in a clinical trial, please click here
Name(Required)
By submitting, you are agreeing to our terms and privacy policy
This field is for validation purposes and should be left unchanged.

Contact Us

Name(Required)
By submitting, you are agreeing to our terms and privacy policy
This field is for validation purposes and should be left unchanged.